Ignite Creation Date:
2024-07-17 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06494423
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-07-02
Brief Title:
Employment Support After Hematopoietic Stem Cell Transplantation
Sponsor:
MGH Institute of Health Professions
Organization:
MGH Institute of Health Professions
Study Overview
Official Title:
Supportive Care Intervention Development to Address Employment Concerns After Allogeneic Hematopoietic Stem Cell Transplantation
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
WorkS
Brief Summary:
This is a feasibility study of a Work Support WorkS intervention designed to ameliorate employment challenges for people preparing to return to work after allogeneic stem cell transplantation The aim of this study is to evaluate proof of concept by
1 examining the feasibility and acceptability of the WorkS intervention and the study procedures and
2 exploring the preliminary effects of WorkS for improving patient-reported return-to-work self-efficacy work status quality of life and financial toxicity
1 examining the feasibility and acceptability of the WorkS intervention and the study procedures and
2 exploring the preliminary effects of WorkS for improving patient-reported return-to-work self-efficacy work status quality of life and financial toxicity
Detailed Description:
Participants will be recruited from MGH Cancer Center The intervention will be delivered at MGH Institute of Health Professions IHP and investigators at MGH IHP will be involved in recruiting participants and collectingmanaging data
Participants will be enrolled in the study for approximately six months following the schedule below
Enrollment into study HSCT recipients will be recruited into the study approximately six months post HSCT - one month
Baseline assessment To be completed within 3 weeks of completing informed consent
WorkS Appointment 1 and 2 To be completed within a 2-month period after completing the baseline assessment Ideally the appointments will be approximately one month apart but can be timed whenever in the 2-month window that is preferred by the participant
Exit assessment To be completed within 3 weeks of completing Appointment 2
Final assessment Return to work status at 12 months post HSCT - three weeks
Participants will be enrolled in the study for approximately six months following the schedule below
Enrollment into study HSCT recipients will be recruited into the study approximately six months post HSCT - one month
Baseline assessment To be completed within 3 weeks of completing informed consent
WorkS Appointment 1 and 2 To be completed within a 2-month period after completing the baseline assessment Ideally the appointments will be approximately one month apart but can be timed whenever in the 2-month window that is preferred by the participant
Exit assessment To be completed within 3 weeks of completing Appointment 2
Final assessment Return to work status at 12 months post HSCT - three weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None